Our mission
Announce news
Subscribe
← Latest venture news
Discover UK startups operating in the
Biotechnology
sector
£14m
Enhanced Genomics raises £14m Series A from investors to advance therapeutics pipeline with its 3D multi-omics platform
Series A
Biotechnology
Sep 16, 2025
🔗
enhancedgenomics.com
£24m
Alchemab Therapeutics raises £24m Series A extension led by Ono Venture Investment to advance AI-enabled antibody platform
Follow-on
Biotechnology
Sep 9, 2025
🔗
alchemab.com
£2.5m
BoobyBiome secures £2.5m seed round led by Empirical Ventures to advance breast milk microbiome tech
Seed
Biotechnology
Sep 8, 2025
🔗
boobybiome.com
£50m
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
Series B
Biotechnology
Sep 8, 2025
🔗
nrgtherapeutics.com
£60m
Charm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drug
Series B
Biotechnology
Sep 2, 2025
🔗
charmtx.com
£4.5m
EnsiliTech raises £4.5m seed round led by Eos Advisory to transform global medicine storage and transport
Seed
Biotechnology
Aug 28, 2025
🔗
ensilitech.com
£3.8m
Centauri Therapeutics secures a further £3.8m from CARB-X to advance antimicrobial candidate into clinical trials
Follow-on
Biotechnology
Jul 29, 2025
🔗
centauritherapeutics.com
£25m
Portal Biotech secures £25m Series A led by NATO Innovation Fund and Earlybird to pioneer full-length protein sequencing
Series A
Biotechnology
Jul 1, 2025
🔗
portalbiotech.com
£20m
Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies
Seed
Biotechnology
Jul 1, 2025
🔗
laverocktx.com
£90m
CellCentric raises £90m Series C led by RA Capital and Forbion to advance first-in-class cancer drug
Series C
Biotechnology
May 19, 2025
🔗
cellcentric.com
£515k
Cellestial Health raises £515k pre-seed round led by Zinc VC to develop astrocyte-targeting drugs for Parkinson’s
Pre-seed
Biotechnology
May 9, 2025
🔗
cellestialhealth.com
£1.3m
AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
Seed
Biotechnology
May 1, 2025
🔗
amplydiscovery.com
£58m
Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline
Series A
Biotechnology
Mar 17, 2025
🔗
maxiontherapeutics.com
£1.5m
StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy
Seed
Biotechnology
Mar 11, 2025
🔗
stimoxygen.com
£24m
TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments
Seed
Biotechnology
Mar 5, 2025
🔗
trimtechtherapeutics.com
£850k
Monument Therapeutics secures £850k led by ACF Investors to advance schizophrenia treatment with MT1988
Equity
Biotechnology
Feb 25, 2025
🔗
monumenttx.com
£3.4m
uFraction8 secures £3.4m in further funding post Foresight investment to advance biotech filtration technology
Equity
Biotechnology
Feb 24, 2025
🔗
ufraction8.com
£40m
Latent Labs raises £40m Series A led by Radical Ventures and Sofinnova Partners to advance AI protein design
Series A
Biotechnology
Feb 13, 2025
🔗
latentlabs.com
£45m
Lindus Health raises a £45m Series B led by Balderton to transform the clinical trial landscape
Series B
Biotechnology
Jan 22, 2025
🔗
lindushealth.com
£334m
Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies
Series A
Biotechnology
Jan 9, 2025
🔗
verdivabio.com
£3m
Concinnity Genetics raises £3m seed round led by Eos Advisory to establish RNA-based gene therapy control systems
Seed
Biotechnology
Dec 16, 2024
🔗
concinnitygenetics.com
£1.2m
Newcells raises further £1.2m funding for laboratory models that speed up drug development
Follow-on
Biotechnology
Dec 5, 2024
🔗
newcellsbiotech.co.uk
£5m
Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology
Equity
Biotechnology
Nov 19, 2024
🔗
cytomos.com
£60m
Blue Earth Therapeutics completes £60m Series A to accelerate development of next generation targeted radioligand therapies
Series A
Biotechnology
Oct 30, 2024
🔗
blueearththerapeutics.com
£10m
ExpressionEdits raises £10m seed round to advance protein expression using AI-driven intronisation technology
Seed
Biotechnology
May 29, 2024
🔗
expressionedits.com